In The News Posted February 2, 2019 Share Posted February 2, 2019 WAYNE, Pa., Feb. 1, 2019 /PRNewswire/ -- On February 1, 2019, the Federal Food and Drug Administration (FDA) issued a public statement warning compounders "not to use glutathione-L-reduced powder distributed by Letco Medical, Decatur, Alabama, to compound sterile injectable drugs for... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.